|
Name |
28-acetoxy-12β,15α,25-trihydroxyergosta-4,6,8(14),22-tetraen-3-one
|
Molecular Formula | C30H42O6 | |
IUPAC Name* |
[5-(12,15-dihydroxy-10,13-dimethyl-3-oxo-1,2,9,11,12,15,16,17-octahydrocyclopenta[a]phenanthren-17-yl)-2-(2-hydroxypropan-2-yl)hex-3-enyl]acetate
|
|
SMILES |
CC(=O)OCC(C=CC(C)C1CC(O)C2=C3C=CC4=CC(=O)CCC4(C)C3CC(O)C21C)C(C)(C)O
|
|
InChI |
InChI=1S/C30H42O6/c1-17(7-8-20(28(3,4)35)16-36-18(2)31)23-14-25(33)27-22-10-9-19-13-21(32)11-12-29(19,5)24(22)15-26(34)30(23,27)6/h7-10,13,17,20,23-26,33-35H,11-12,14-16H2,1-6H3/b8-7+/t17-,20-,23-,24+,25+,26-,29+,30+/m1/s1
|
|
InChIKey |
ZQWAPIPOQSYCJS-GKPPARAWSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 498.66 | ALogp: | 4.1 |
HBD: | 3 | HBA: | 6 |
Rotatable Bonds: | 6 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 104.1 | Aromatic Rings: | 4 |
Heavy Atoms: | 36 | QED Weighted: | 0.363 |
Caco-2 Permeability: | -4.825 | MDCK Permeability: | 0.00002290 |
Pgp-inhibitor: | 0.998 | Pgp-substrate: | 0.235 |
Human Intestinal Absorption (HIA): | 0.853 | 20% Bioavailability (F20%): | 0.805 |
30% Bioavailability (F30%): | 0.285 |
Blood-Brain-Barrier Penetration (BBB): | 0.983 | Plasma Protein Binding (PPB): | 91.20% |
Volume Distribution (VD): | 1.32 | Fu: | 8.25% |
CYP1A2-inhibitor: | 0.005 | CYP1A2-substrate: | 0.089 |
CYP2C19-inhibitor: | 0.016 | CYP2C19-substrate: | 0.843 |
CYP2C9-inhibitor: | 0.027 | CYP2C9-substrate: | 0.142 |
CYP2D6-inhibitor: | 0.003 | CYP2D6-substrate: | 0.159 |
CYP3A4-inhibitor: | 0.481 | CYP3A4-substrate: | 0.71 |
Clearance (CL): | 3.09 | Half-life (T1/2): | 0.304 |
hERG Blockers: | 0.116 | Human Hepatotoxicity (H-HT): | 0.025 |
Drug-inuced Liver Injury (DILI): | 0.077 | AMES Toxicity: | 0.015 |
Rat Oral Acute Toxicity: | 0.238 | Maximum Recommended Daily Dose: | 0.923 |
Skin Sensitization: | 0.128 | Carcinogencity: | 0.641 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.008 |
Respiratory Toxicity: | 0.863 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC004999 | 0.824 | D0F1UL | 0.309 | ||||
ENC004366 | 0.794 | D0N1TP | 0.307 | ||||
ENC004998 | 0.542 | D04SFH | 0.279 | ||||
ENC003739 | 0.504 | D0W5LS | 0.279 | ||||
ENC003880 | 0.455 | D0F7NQ | 0.277 | ||||
ENC003368 | 0.440 | D0X4RS | 0.275 | ||||
ENC001861 | 0.439 | D02CJX | 0.274 | ||||
ENC004022 | 0.439 | D05BTM | 0.270 | ||||
ENC004737 | 0.439 | D0G5CF | 0.270 | ||||
ENC004834 | 0.421 | D04GJN | 0.269 |